2020 UK共识工作组共识声明：糖尿病视网膜病变与黄斑水肿的路径和管理

2020-06-04 国外眼科专家协作组（统称） Eye (Lond) . 2020 Jun;34(Suppl 1):1-51.

糖尿病视网膜病变（DR）的管理，随着诊断和治疗新技术的出现，在过去的十年间发生了很大变化。本文主要内伤涉及糖尿病视网膜病变与黄斑水肿的管理路径和建议。

中文标题：

英文标题：

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

发布机构：

国外眼科专家协作组（统称）

发布日期：

2020-06-04

简要介绍：

糖尿病视网膜病变（DR）的管理，随着诊断和治疗新技术的出现，在过去的十年间发生了很大变化。本文主要内伤涉及糖尿病视网膜病变与黄斑水肿的管理路径和建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=696ab1c00191e95b, title=2020 UK共识工作组共识声明：糖尿病视网膜病变与黄斑水肿的路径和管理, enTitle=Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group, guiderFrom=Eye (Lond) . 2020 Jun;34(Suppl 1):1-51., authorId=0, author=, summary=糖尿病视网膜病变（DR）的管理，随着诊断和治疗新技术的出现，在过去的十年间发生了很大变化。本文主要内伤涉及糖尿病视网膜病变与黄斑水肿的管理路径和建议。, cover=https://img.medsci.cn/2020612/1591975638812_2020535.jpg, journalId=0, articlesId=null, associationId=959, associationName=国外眼科专家协作组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jun 04 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>糖尿病视网膜病变（DR）的管理，随着诊断和治疗新技术的出现，在过去的十年间发生了很大变化。本文主要内伤涉及糖尿病视网膜病变与黄斑水肿的管理路径和建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=6678, tagName=糖尿病视网膜病变)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=6678, guiderKeyword=糖尿病视网膜病变, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4792, appHits=234, showAppHits=0, pcHits=844, showPcHits=4558, likes=3, shares=16, comments=12, approvalStatus=1, publishedTime=Fri Jun 12 23:34:33 CST 2020, publishedTimeString=2020-06-04, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Fri Jun 12 23:27:31 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 03:44:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 UK共识工作组共识声明：糖尿病视网膜病变与黄斑水肿的路径和管理.pdf)])

2020 UK共识工作组共识声明：糖尿病视网膜病变与黄斑水肿的路径和管理.pdf

下载请点击：

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1184162, encodeId=f10c11841625f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:52:24 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180198, encodeId=94c91180198dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:25:29 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083205, encodeId=c3bd108320518, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2883108677, createdName=4977194, createdTime=Wed Dec 22 20:49:36 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924485, encodeId=d249924485b9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sat Feb 13 21:30:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891572, encodeId=929f8915e201, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4325398811, createdName=ms4000002070088423, createdTime=Mon Oct 12 19:13:05 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2022-01-14 14700d3fm94(暂无昵称)

学习了

71 0
[GetPortalCommentsPageByObjectIdResponse(id=1184162, encodeId=f10c11841625f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:52:24 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180198, encodeId=94c91180198dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:25:29 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083205, encodeId=c3bd108320518, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2883108677, createdName=4977194, createdTime=Wed Dec 22 20:49:36 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924485, encodeId=d249924485b9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sat Feb 13 21:30:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891572, encodeId=929f8915e201, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4325398811, createdName=ms4000002070088423, createdTime=Mon Oct 12 19:13:05 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2022-01-03 ms3000000727805956

学习了

76 0
[GetPortalCommentsPageByObjectIdResponse(id=1184162, encodeId=f10c11841625f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:52:24 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180198, encodeId=94c91180198dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:25:29 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083205, encodeId=c3bd108320518, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2883108677, createdName=4977194, createdTime=Wed Dec 22 20:49:36 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924485, encodeId=d249924485b9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sat Feb 13 21:30:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891572, encodeId=929f8915e201, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4325398811, createdName=ms4000002070088423, createdTime=Mon Oct 12 19:13:05 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2021-12-22 4977194

好

68 0
[GetPortalCommentsPageByObjectIdResponse(id=1184162, encodeId=f10c11841625f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:52:24 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180198, encodeId=94c91180198dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:25:29 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083205, encodeId=c3bd108320518, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2883108677, createdName=4977194, createdTime=Wed Dec 22 20:49:36 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924485, encodeId=d249924485b9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sat Feb 13 21:30:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891572, encodeId=929f8915e201, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4325398811, createdName=ms4000002070088423, createdTime=Mon Oct 12 19:13:05 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2021-02-13 wuxiaoman

好

89 0
[GetPortalCommentsPageByObjectIdResponse(id=1184162, encodeId=f10c11841625f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:52:24 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180198, encodeId=94c91180198dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:25:29 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083205, encodeId=c3bd108320518, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2883108677, createdName=4977194, createdTime=Wed Dec 22 20:49:36 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924485, encodeId=d249924485b9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sat Feb 13 21:30:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891572, encodeId=929f8915e201, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4325398811, createdName=ms4000002070088423, createdTime=Mon Oct 12 19:13:05 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2020-10-12 ms4000002070088423

好

106 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌科指南

2020 UK共识工作组共识声明：糖尿病视网膜病变与黄斑水肿的路径和管理

相关指南

拓展阅读

科室

工具

服务